
	Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries, that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions &mdash; among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey &mdash;&nbsp; and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
	
	The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
	
	Below is an overview of our flagship products.
	
	Our customers are doing momentous things, and we are uniquely positioned to show our customers the &lsquo;art of the possible&rsquo;.
	
	For more than 130 years we have shared their commitment to transforming and advancing science, health and technology. We understand the worlds in which clinicians, educators, and academic and corporate researchers work, the outcomes they want to achieve and the challenges they face in achieving them.
	
	We have a responsibility to use that understanding to create highly effective solutions that enable our customers to leverage the vast potential of information to advance science, health and technology in ways that they could not do alone, and to anticipate the new ways customers will want to use information in the future. That is what we mean by &lsquo;leading the way&rsquo;.
	&nbsp;
